Back to Authors

Wang, Guangyu

https://orcid.org/0000-0003-4803-7200

Mayo Clinic

Houston Methodist

Citations 12

An ERK5-NRF2 Axis Mediates Senescence-Associated Stemness and Atherosclerosis
Abe, Jun‐ichi , Imanishi, Masaki , Li, Shengyu , Zhang, Aijun , Ko, Kyung Ae , Samanthapudi, Venkata Subrahman K, Lee, Ling-Ling, Bojorges, Angelica Paniagua, Gi, Young Jin , Hobbs, Brian P. , Herrmann, Joerg , Chini, Eduardo N. , Shen, Ying H. , Schadler, Keri , Nguyen, Thi-Hong-Minh, Gupte, Anisha A. , Reyes‐Gibby, Cielito C. , Abe, Rei , Pownall, Henry J. , Yoshimoto, Momoko , Fujiwara, Keigi , Hamilton, Dale J. , Le, Nhat-Tu , Kotla, Sivareddy , Li, Shengyu , Deswal, Anita M , Shen, Ying H , Reyes-Gibby, Cielito , Abe, Rei J , Dantzer, Robert , Palaskas, Nicolas L , Cooke, John P , Pownall, Henry J , Yoshimoto, Momoko , Fujiwara, Keigi , Hamilton, Dale J , Burks, Jared K , Wang, Guangyu , Kotla, Sivareddy , Abe, Jun-Ichi , Li, Shengyu , Zhang, Aijun , Lin, Steven H. , Schadler, Keri , Yeung, Sai‐Ching J. , Olmsted‐Davis, Elizabeth A. , Krishnan, Sunil , Cooke, John P. , Wang, Guangyu

Circulation Research | June 2, 2023 | Volume: 133 | Issue: 1 | Pages: 25-44

10.1161/circresaha.122.322017 Get It

Background: ERK5 (extracellular signal-regulated kinase 5) is a dual kinase transcription factor containing an N-terminal kinase domain and a C-terminal transcriptional activation domain. Many ERK5 kinase inhibitors have been developed and tested to treat cancer and inflammatory diseases. However, recent data have raised questions about the role of the catalytic activity of ERK5 in proliferation and inflammation. We aimed to investigate how ERK5 reprograms myeloid cells to the proinflammatory senescent phenotype, subsequently leading to atherosclerosis. Methods: A ERK5 S496A (dephosphorylation mimic) knock in (KI) mouse model was generated using CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/clustered regularly interspaced short palindromic repeat–associated 9), and atherosclerosis was characterized by hypercholesterolemia induction. The plaque phenotyping in homozygous ERK5 S496A KI and wild type (WT) mice was studied using imaging mass cytometry. Bone marrow–derived macrophages were isolated from hypercholesterolemic mice and characterized using RNA sequencing and functional in vitro approaches, including senescence, mitochondria reactive oxygen species, and inflammation assays, as well as by metabolic extracellular flux analysis. Results: We show that atherosclerosis was inhibited in ERK5 S496A KI mice. Furthermore, ERK5 S496 phosphorylation mediates both senescence-associated secretory phenotype and senescence-associated stemness by upregulating AHR (aryl hydrocarbon receptor) in plaque and bone marrow–derived macrophages isolated from hypercholesterolemic mice. We also discovered that ERK5 S496 phosphorylation could induce NRF2 (NFE2-related factor 2) SUMOylation at a novel K518 site to inhibit NRF2 transcriptional activity without altering ERK5 catalytic activity and mediates oxidized LDL (low-density lipoprotein)–induced senescence-associated secretory phenotype. Specific ERK5 kinase inhibitors (AX15836 and XMD8-92) also inhibited ERK5 S496 phosphorylation, suggesting the involvement of ERK5 S496 phosphorylation in the anti-inflammatory effects of these ERK5 kinase inhibitors. Conclusions: We discovered a novel mechanism by which the macrophage ERK5-NRF2 axis develops a unique senescence-associated secretory phenotype/stemness phenotype by upregulating AHR to engender atherogenesis. The finding of senescence-associated stemness phenotype provides a molecular explanation to resolve the paradox of senescence in proliferative plaque by permitting myeloid cells to escape the senescence-induced cell cycle arrest during atherosclerosis formation.
Characterization and identification of long non-coding RNAs based on feature relationship
Wang, Guangyu , Yin, Hongyan , Li, Boyang , Yu, Chunlei , Wang, Fan , Xu, Xingjian , Cao, Jiabao, Bào, Yīmíng , Wang, Liguo , Abbasi, Amir Ali , Bajić, Vladimir B. , Ma, Lina , Zhang, Zhang , Wang, Liguo , Wang, Guangyu , Cao, Jiabao

Bioinformatics | January 8, 2019 | Volume: 35 | Issue: 17 | Pages: 2949-2956

10.1093/bioinformatics/btz008 Get It

Abstract Motivation The significance of long non-coding RNAs (lncRNAs) in many biological processes and diseases has gained intense interests over the past several years. However, computational identification of lncRNAs in a wide range of species remains challenging; it requires prior knowledge of well-established sequences and annotations or species-specific training data, but the reality is that only a limited number of species have high-quality sequences and annotations. Results Here we first characterize lncRNAs in contrast to protein-coding RNAs based on feature relationship and find that the feature relationship between open reading frame length and guanine-cytosine (GC) content presents universally substantial divergence in lncRNAs and protein-coding RNAs, as observed in a broad variety of species. Based on the feature relationship, accordingly, we further present LGC, a novel algorithm for identifying lncRNAs that is able to accurately distinguish lncRNAs from protein-coding RNAs in a cross-species manner without any prior knowledge. As validated on large-scale empirical datasets, comparative results show that LGC outperforms existing algorithms by achieving higher accuracy, well-balanced sensitivity and specificity, and is robustly effective (>90% accuracy) in discriminating lncRNAs from protein-coding RNAs across diverse species that range from plants to mammals. To our knowledge, this study, for the first time, differentially characterizes lncRNAs and protein-coding RNAs based on feature relationship, which is further applied in computational identification of lncRNAs. Taken together, our study represents a significant advance in characterization and identification of lncRNAs and LGC thus bears broad potential utility for computational analysis of lncRNAs in a wide range of species. Availability and implementation LGC web server is publicly available at http://bigd.big.ac.cn/lgc/calculator. The scripts and data can be downloaded at http://bigd.big.ac.cn/biocode/tools/BT000004. Supplementary information Supplementary data are available at Bioinformatics online.